Theme-Logo
  • Login
  • Home
  • Course
  • Publication
  • Theses
  • Reports
  • Published books
  • Workshops / Conferences
  • Supervised PhD
  • Supervised MSc
  • Supervised projects
  • Education
  • Language skills
  • Positions
  • Memberships and awards
  • Committees
  • Experience
  • Scientific activites
  • In links
  • Outgoinglinks
  • News
  • Gallery
publication name INTERLEUKIN-17 IS A CAUSE OR A RESULT IN STSTEMIC LUPUS ERYTHEMATOSUS ?
Authors SEHAM GOUDA AMEEN,NEVEEN AHMAD ABDUL-HAFEEZ,EMAN RAMADAN ABD EL-GWAD,FATEMAH ALI ELSHABACY
year 2016
keywords systemic lupus erythematosus ,CD4⁺ T-cells ,Interleukin-17 .
journal
volume Not Available
issue Not Available
pages Not Available
publisher Not Available
Local/International International
Paper Link Not Available
Full paper download
Supplementary materials Not Available
Abstract

Systemic lupus erythematosus (SLE) is an inflammatory disease in which an autoimmune process attacks several tissues and organs including the skin , kidney, and joints .Mechanisms of tissue damage in patients with SLE involve autoantibody and immune complex deposition , as well as infiltration of tissues by lymphocytes . The IL-17 is produced by several cell types that include CD4⁺ T- cells , CD8⁺ T- cells , CD3⁺CD4⁻CD8⁻ T- cells , γδ T- cells , natural killer cell and neutrophils. IL-17 plays an important role in the immune response against certain pathogens. IL-17 has pro-inflammatory capacities exerted through its ability to induce secretion of chemokines such as IL-8 , monocyte chemoattractant protein-1 (MCP-1), and growth related oncogene protein-α , which recruit monocytes and neutrophils . IL-17-producing cells have been implicated in the pathogenesis of a wide range of inflammatory and autoimmune diseases including psoriasis, rheumatoid arthritis (RA), inflammatory bowel disease (IBD) , systemic sclerosis , and systemic lupus erythematosus (SLE) .

Benha University © 2023 Designed and developed by portal team - Benha University